Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Social Phobia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Social Phobia to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Social Phobia Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 34
Appendix 84
Abbreviations 84
Definitions 84
Research Methodology 85
Secondary Research 85
About GlobalData 86
Contact Us 86
Disclaimer 86
Source 86

List of Tables
Social Phobia Therapeutics, Global, Clinical Trials by Region, 2018* 6
Social Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Social Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Social Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 10
Social Phobia Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Social Phobia Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Social Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
Social Phobia Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
Proportion of Social Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 16
Social Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Social Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Social Phobia to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 20
Social Phobia Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Social Phobia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Social Phobia Therapeutics, Global, Clinical Trials by Phase, 2018* 23
Social Phobia Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
Social Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Social Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
Social Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
Social Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 28
Social Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Social Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Social Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33

List of Figures
Social Phobia Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Social Phobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Social Phobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Social Phobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 10
Social Phobia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Social Phobia Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Social Phobia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
Proportion of Social Phobia to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
Social Phobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Social Phobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Social Phobia to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 19
Social Phobia Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Social Phobia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Social Phobia Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
Social Phobia Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
Social Phobia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Social Phobia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
Social Phobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
Social Phobia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 28
Social Phobia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
Social Phobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
Social Phobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33
GlobalData Methodology 85

Companies Mentioned
- GlaxoSmithKline Plc
- Pfizer Inc
- Mylan NV
- The Lundbeck Foundation
- Synthon Holdings BV
- Syneos Health Inc
- Alfred E. Tiefenbacher GmbH & Co KG
- Morningside Healthcare Ltd
- AstraZeneca Plc
- Allergan Plc